Wild update in the biotech world: An 8-year-old in Brazil died after getting Sarepta’s Elevidys gene therapy for Duchenne muscular dystrophy, but both Sarepta and Roche are saying it wasn’t the treatment—looks like a bad flu was to blame. Still, the FDA is digging in, and Brazil has paused all Elevidys sales just in case. Sarepta’s stock took another hit, and everyone’s now questioning how safe these gene therapies really are. Big pharma drama! #Health #BodyHealth #biotechnews